213 related articles for article (PubMed ID: 15752160)
1. Plateletpheresis does not cause long-standing platelet-derived growth factor release into the donor blood.
Zimmermann R; Loew D; Weisbach V; Strasser E; Ringwald J; Zingsem J; Eckstein R
Transfusion; 2005 Mar; 45(3):414-9. PubMed ID: 15752160
[TBL] [Abstract][Full Text] [Related]
2. Preparation of highly concentrated and white cell-poor platelet-rich plasma by plateletpheresis.
Zimmermann R; Reske S; Metzler P; Schlegel A; Ringwald J; Eckstein R
Vox Sang; 2008 Jul; 95(1):20-5. PubMed ID: 18444946
[TBL] [Abstract][Full Text] [Related]
3. Quantitative assessment of the kinetics of growth factors release from platelet gel.
Su CY; Kuo YP; Nieh HL; Tseng YH; Burnouf T
Transfusion; 2008 Nov; 48(11):2414-20. PubMed ID: 18694465
[TBL] [Abstract][Full Text] [Related]
4. Prevention of cytokine accumulation in platelets obtained with the COBE spectra apheresis system.
Palmer DS; Aye MT; Dumont L; Dumont D; McCombie N; Giulivi A; Rutherford B; Trudel E; Hashemi-Tavoularis S
Vox Sang; 1998; 75(2):115-23. PubMed ID: 9784664
[TBL] [Abstract][Full Text] [Related]
5. The contribution of platelet-derived growth factor, transforming growth factor-beta1, and insulin-like growth factor-I in platelet-rich plasma to the proliferation of osteoblast-like cells.
Ogino Y; Ayukawa Y; Kukita T; Koyano K
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Jun; 101(6):724-9. PubMed ID: 16731390
[TBL] [Abstract][Full Text] [Related]
6. Growth factor levels in the platelet-rich plasma produced by 2 different methods: curasan-type PRP kit versus PCCS PRP system.
Weibrich G; Kleis WK; Hafner G
Int J Oral Maxillofac Implants; 2002; 17(2):184-90. PubMed ID: 11958400
[TBL] [Abstract][Full Text] [Related]
7. Technique for producing platelet-rich plasma and platelet concentrate: background and process.
Gonshor A
Int J Periodontics Restorative Dent; 2002 Dec; 22(6):547-57. PubMed ID: 12516826
[TBL] [Abstract][Full Text] [Related]
8. Platelet function in variable platelet split products intended for neonatal transfusion.
Strasser EF; Stachel DK; Schwarzkopf P; Ringwald J; Weisbach V; Zimmermann R; Zingsem J; Eckstein R
Transfusion; 2006 May; 46(5):757-65. PubMed ID: 16686843
[TBL] [Abstract][Full Text] [Related]
9. Enoxaparin but not unfractionated heparin causes a dose-dependent increase in plasma TGF-beta 1 during haemodialysis: a cross-over study.
Naumnik B; Borawski J; Pawlak K; Mysliwiec M
Nephrol Dial Transplant; 2007 Jun; 22(6):1690-6. PubMed ID: 17389624
[TBL] [Abstract][Full Text] [Related]
10. [Preparation of autologous platelet-rich gel for diabetic refractory dermal ulcer and growth factors analysis from it].
Yuan N; Wang C; Wang Y; Yu T; Long Y; Zhang X; Ran X
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Apr; 22(4):468-71. PubMed ID: 18575451
[TBL] [Abstract][Full Text] [Related]
11. Platelet content and growth factor release in platelet-rich plasma: a comparison of four different systems.
Leitner GC; Gruber R; Neumüller J; Wagner A; Kloimstein P; Höcker P; Körmöczi GF; Buchta C
Vox Sang; 2006 Aug; 91(2):135-9. PubMed ID: 16907874
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the platelet concentrate collection system with the plasma-rich-in-growth-factors kit to produce platelet-rich plasma: a technical report.
Weibrich G; Kleis WK; Hitzler WE; Hafner G
Int J Oral Maxillofac Implants; 2005; 20(1):118-23. PubMed ID: 15747683
[TBL] [Abstract][Full Text] [Related]
13. Impact of different hold time before addition of platelet additive solution on the in vitro quality of apheresis platelets.
Ringwald J; Haager B; Krex D; Zimmermann R; Strasser E; Antoon M; De Schrijver E; Eckstein R
Transfusion; 2006 Jun; 46(6):942-8. PubMed ID: 16734810
[TBL] [Abstract][Full Text] [Related]
14. Role of platelet-derived growth factor and transforming growth factor beta1 the in the regulation of metalloproteinase expressions.
Borrelli V; di Marzo L; Sapienza P; Colasanti M; Moroni E; Cavallaro A
Surgery; 2006 Sep; 140(3):454-63. PubMed ID: 16934609
[TBL] [Abstract][Full Text] [Related]
15. Platelet-rich plasma preparation using three devices: implications for platelet activation and platelet growth factor release.
Everts PA; Brown Mahoney C; Hoffmann JJ; Schönberger JP; Box HA; van Zundert A; Knape JT
Growth Factors; 2006 Sep; 24(3):165-71. PubMed ID: 17079200
[TBL] [Abstract][Full Text] [Related]
16. Platelets stimulate fibroblast-mediated contraction of collagen gels.
Zagai U; Fredriksson K; Rennard SI; Lundahl J; Sköld CM
Respir Res; 2003; 4(1):13. PubMed ID: 14624704
[TBL] [Abstract][Full Text] [Related]
17. Solvent/detergent treatment of platelet concentrates enhances the release of growth factors.
Burnouf T; Tseng YH; Kuo YP; Su CY
Transfusion; 2008 Jun; 48(6):1090-8. PubMed ID: 18373502
[TBL] [Abstract][Full Text] [Related]
18. [Electron-immunostaining characteristics of platelet-derived growth factor, transforming growth factor beta1 and their receptors in epiretinal membranes].
Wang F; Xu X; Zhang X; Yan Y
Zhonghua Yan Ke Za Zhi; 2000 Sep; 36(5):369-71, 24. PubMed ID: 11853632
[TBL] [Abstract][Full Text] [Related]
19. Effect of different bone substitutes on the concentration of growth factors in platelet-rich plasma.
Hee Soon Cho ; Park SY; Kim S; Sang Keun Bae ; Duk Seop Shin ; Ahn MW
J Biomater Appl; 2008 May; 22(6):545-57. PubMed ID: 18194993
[TBL] [Abstract][Full Text] [Related]
20. The serum levels of growth factors: PDGF, TGF-beta and VEGF are increased after strenuous physical exercise.
Czarkowska-Paczek B; Bartlomiejczyk I; Przybylski J
J Physiol Pharmacol; 2006 Jun; 57(2):189-97. PubMed ID: 16845225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
